← Back to Search

MOSAIC Plus for Intimate Partner Violence (MOSAIC Plus Trial)

N/A

Waitlist Available

Research Sponsored by Michigan State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have elevated depressive and/or PTSD symptoms as assessed by Patient Health Questionnaire (PHQ-9) with a cutoff point of ≥9, and/or the Davidson Trauma Scale (DTS) with a cut-off point of ≥40.

Aged 18 or above

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3, 6 and 9 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test a new program (MOSAIC Plus) to reduce depression and PTSD in pregnant women and mothers who experience IPV. It will enroll those who screen positive for elevated symptoms and last 6 months.

Who is the study for?

This trial is for pregnant women or mothers with children under 5 who have faced intimate partner violence (IPV) in the last 6 months and are showing signs of depression or PTSD. Participants must be over 18, able to provide contact info for two people who can locate them, and understand English well enough for consent and assessments.

What is being tested?

The MOSAIC Plus intervention is being tested to see if it helps reduce symptoms of depression and PTSD while preventing further IPV. It combines interpersonal therapy techniques with the existing MOSAIC support program over a period of six months after joining the study.

What are the potential side effects?

Since this trial involves psychological support interventions rather than medications, traditional side effects like those seen with drugs are not expected. However, discussing traumatic experiences could potentially lead to temporary increases in distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have significant depression or PTSD symptoms.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3, 6 and 9 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3, 6 and 9 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6 and 9 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Quality of Working Relationship

Reduction in Posttraumatic Stress Disorder Symptoms

Reduction in depressive symptoms

+2 more

Secondary study objectives

Effectiveness Obtaining Resources

Functioning

General health and wellbeing

+3 more

Other study objectives

Provider Competencies

Quality of working relationship-provider perspective

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: MOSAIC PlusExperimental Treatment1 Intervention

"Mother AdvocateS In the Community (MOSAIC) Plus" intervention to reduce depressive and PTSD symptoms and prevent additional IPV among pregnant women and mothers with children under 5 experiencing IPV. The MOSAIC Plus intervention will integrate IPT principles and skills into the MOSAIC intervention in order to expand it to address consequences of IPV, including depression and PTSD symptoms.

Group II: MOSAICActive Control1 Intervention

Those in the active comparator will receive the "Mother AdvocateS In the Community (MOSAIC) Plus" intervention to reduce depressive and PTSD symptoms and prevent additional IPV among pregnant women and mothers with children under 5 experiencing IPV.

0 / 2Eligibility criteria met